Shandong Weigao Group Medical Polymer Company Limited (HKG:1066)
Hong Kong · Delayed Price · Currency is HKD 5.66
+0.03 (0.53%)
Oct 24, 2025, 2:45 PM HKT
HKG:1066 Market Cap
HKG:1066 has a market cap or net worth of 25.61 billion as of October 24, 2025. Its market cap has decreased by -8.89% in one year.
Market Cap
25.61B
Enterprise Value
22.82B
Revenue
14.35B
Ranking
n/a
PE Ratio
11.94
Stock Price
5.66
Market Cap Chart
Since February 27, 2004, HKG:1066's market cap has increased from 572.70M to 25.61B, an increase of 4,371.75%. That is a compound annual growth rate of 19.17%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 24, 2025 | 25.70B | 22.24% |
| Dec 31, 2024 | 21.02B | -39.55% |
| Dec 29, 2023 | 34.78B | -40.64% |
| Dec 30, 2022 | 58.60B | 33.16% |
| Dec 31, 2021 | 44.00B | -44.46% |
| Dec 31, 2020 | 79.23B | 87.58% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BeOne Medicines AG | 265.24B |
| Hansoh Pharmaceutical Group Company | 208.01B |
| JD Health International | 197.69B |
| Innovent Biologics | 146.59B |
| WuXi Biologics | 144.30B |
| Sino Biopharmaceutical | 125.14B |
| Akeso | 106.12B |
| Sichuan Kelun-Biotech Biopharmaceutical | 99.57B |